FDA Approves Pimjetmi (pimicotinib) for Patients with Tenosynovial Giant Cell Tumor

Nov 10, 2026 - 20:00
 0  0
November 10, 2026 -- EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the US and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved Pimjetmi (pimicotinib), a once-daily oral colony...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0